# Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC

> **NCT00385606** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Cancer Institute, Naples** · enrollment: 400 (actual)

## Conditions studied

- Advanced Non-small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** prolonged continuous infusion gemcitabine
- **DRUG:** cisplatin
- **DRUG:** rofecoxib

## Key facts

- **NCT ID:** NCT00385606
- **Lead sponsor:** National Cancer Institute, Naples
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2005-12
- **Final completion:** 2006-07
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00385606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00385606, "Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00385606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*